Another immune signature detected in critically ill patients with COVID-19 includes the type 2 cytokines IL-4, IL-5, IL-13, and TSLP, related to noninfectious lung diseases (Choreño-Parra and others 2021). This evidence concerns the gene IL13 and COVID-19.